Hahn, Y. et al. Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases. Proc. Natl Acad. Sci. USA 101, 13257–13261 (2004).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salokas, K., Weldatsadik, R. G. & Varjosalo, M. Human transcription factor and protein kinase gene fusions in human cancer. Sci. Rep. 10, 14169 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laskin, J. et al. NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. Ann. Oncol. 31, 1693–1703 (2020).

Article  CAS  PubMed  Google Scholar 

Futreal, P. A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177–183 (2004).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dehghannasiri, R. et al. Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers. Proc. Natl Acad. Sci. USA 116, 15524–15533 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tomlins, S. A. et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448, 595–599 (2007).

Article  CAS  PubMed  Google Scholar 

Kerbs, P. et al. Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements. Haematologica 107, 100–111 (2022).

Article  CAS  PubMed  Google Scholar 

Quintas-Cardama, A. & Cortes, J. E. Chronic myeloid leukemia: Diagnosis and treatment. Mayo Clin. Proc. 81, 973–988 (2006).

Article  CAS  PubMed  Google Scholar 

Quintas-Cardama, A. & Cortes, J. Molecular biology of BCR-ABL1-positive chronic myeloid leukemia. Blood 113, 1619–1630 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644–648 (2005).

Article  CAS  PubMed  Google Scholar 

Kumar-Sinha, C., Kalyana-Sundaram, S. & Chinnaiyan, A. M. Landscape of gene fusions in epithelial cancers: Seq and ye shall find. Genome Med. 7, 129 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Okamura, R. et al. Analysis of NTRK alterations in pan-cancer adult and pediatric malignancies: Implications for NTRK-targeted therapeutics. JCO Precis. Oncol. 2018, PO.18.00183 (2018).

PubMed  Google Scholar 

Mitelman, F., Johansson, B. & Mertens, F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 7, 233–245 (2007).

Article  CAS  PubMed  Google Scholar 

Zehir, A. et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703–713 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stransky, N., Cerami, E., Schalm, S., Kim, J. L. & Lengauer, C. The landscape of kinase fusions in cancer. Nat. Commun. 5, 4846 (2014).

Article  CAS  PubMed  Google Scholar 

Gupta, B., Gosa Barrett, L. & Liu, S. V. NRG1 fusions in NSCLC: Being eNRGy conscious. Lung Cancer (Auckl) 15, 143–148 (2024).

PubMed  Google Scholar 

Topham, J. T. et al. Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma. Nat. Commun. 13, 5941 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fusco, M. J. et al. Identification of targetable gene fusions and structural rearrangements to foster precision medicine in KRAS wild-type pancreatic cancer. JCO Precis. Oncol. 5, 65–74 (2021).

Article  Google Scholar 

Philip, P. A. et al. Molecular characterization of KRAS wild-type tumors in patients with pancreatic adenocarcinoma. Clin. Cancer Res. 28, 2704–2714 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao, Z. et al. Anaplastic lymphoma kinase fusions: roles in cancer and therapeutic perspectives. Oncol. Lett. 17, 2020–2030 (2019).

CAS  PubMed  Google Scholar 

Uguen, A. & De Braekeleer, M. ROS1 fusions in cancer: a review. Future Oncol. 12, 1911–1928 (2016).

Article  CAS  PubMed  Google Scholar 

De Luca, A. et al. FGFR fusions in cancer: from diagnostic approaches to therapeutic intervention. Int. J. Mol. Sci. 21, 6856 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Hyung, S. et al. Incidence of FGFR2 amplification and FGFR2 fusion in patients with metastatic cancer using clinical sequencing. J. Oncol. 2022, 9714570 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Parimi, V. et al. Genomic landscape of 891 RET fusions detected across diverse solid tumor types. NPJ Precis. Oncol. 7, 10 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ross, J. S. et al. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy. Int. J. Cancer 138, 881–890 (2016).

Article  CAS  PubMed  Google Scholar 

Nikanjam, M., Okamura, R., Barkauskas, D. A. & Kurzrock, R. Targeting fusions for improved outcomes in oncology treatment. Cancer 126, 1315–1321 (2020).

Article  PubMed  Google Scholar 

Matter, M. S., Chijioke, O., Savic, S. & Bubendorf, L. Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas. Transl. Lung Cancer Res. 9, 2645–2655 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Neumayer, C. et al. Oncogenic addiction of fibrolamellar hepatocellular carcinoma to the fusion kinase DNAJB1-PRKACA. Clin. Cancer Res. 29, 271–278 (2023).

Article  CAS  PubMed  Google Scholar 

Torti, D. & Trusolino, L. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: Promises and perils. EMBO Mol. Med. 3, 623–636 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pagliarini, R., Shao, W. & Sellers, W. R. Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure. EMBO Rep. 16, 280–296 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Looney, A. M., Nawaz, K. & Webster, R. M. Tumour-agnostic therapies. Nat. Rev. Drug Discov. 19, 383–384 (2020).

Article  CAS  PubMed  Google Scholar 

Li, J. et al. A functional genomic approach to actionable gene fusions for precision oncology. Sci. Adv. 8, eabm2382 (2022).

Article  CAS